Matthew A. Ciorba, MD, a professor of medicine and director of the Inflammatory Bowel Disease Center at Washington University School of Medicine in St. Louis, has received a $2.8 million award from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) to evaluate a new treatment in combination with routine radiation and chemotherapy in patients with locally advanced (Stage II or III) rectal cancer.
Ciorba receives grant to evaluate treatment for colorectal cancer
View Content